2m 2m 2m 2m 2m 2m 2m
Prestige Consmer (PBH)
NYSE
$46.05-$0.0010 (-0.002%)
Price as of Jun 23, 2026 6:57 PM EDT- $2.2BMarket Cap
- -46.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Prestige Consmer (PBH)
$46.05-$0.0010 (-0.002%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.1B -4.56% | 1.1B +1.00% | 1.1B -0.21% | 1.1B +3.76% | |
Cost of Revenue | 493.1M -2.02% | 503.3M +0.48% | 500.9M -0.30% | 502.4M +7.78% | |
Gross Profit | 595.6M -6.13% | 634.5M +1.60% | 624.4M -0.14% | 625.3M +0.75% | |
Sales and Marketing Expense | 148.8M -4.46% | 155.7M +1.57% | 153.3M +5.69% | 145.1M -7.81% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 31.3M +3.65% | 30.2M -1.64% | 30.7M -5.98% | 32.6M +1.66% | |
Total Operating Expenses | 286.2M -3.87% | 297.7M +5.56% | 282.0M -56.46% | 647.7M +122.79% | |
Operating Profit | 309.4M -8.13% | 336.8M -1.65% | 342.4M +1,627.68% | -22.4M -106.79% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -42.3M -11.11% | -47.6M -29.08% | -67.2M -2.90% | -69.2M +7.59% | |
Interest Income and Expense and Net | -42.3M -11.11% | -47.6M -29.08% | -67.2M -197.10% | 69.2M +7.59% | |
Total Nonoperating Income and Expense | -9.6M +93.26% | -5.0M -755.29% | 756,000 +132.36% | -2.3M +122.05% | |
Income before Taxes | 257.5M -9.39% | 284.2M +2.96% | 276.0M +393.91% | -93.9M -135.78% | |
Income Taxes | 67.2M -3.43% | 69.6M +4.35% | 66.7M +674.43% | -11.6M -120.34% | |
Extraordinary Items | 0 -100.00% | 12.5M N/A | 0 -100.00% | 370.2M +34,925.26% | |
Net Income | 190.3M -11.32% | 214.6M +2.52% | 209.3M +354.34% | -82.3M -140.07% | |
Net Income from Continuing Operations Applicable to Common | 190.3M -11.32% | 214.6M +2.52% | 209.3M +322.90% | -93.9M -135.78% | |
Basic EPS and Net Income | 3.93 -9.03% | 4.32 +2.61% | 4.21 +355.15% | -1.65 -140.34% | |
Diluted EPS and Net Income | 3.91 -8.86% | 4.29 +2.88% | 4.17 +352.73% | -1.65 -140.84% | |
Basic Weighted Average Shares | 48.5M -2.50% | 49.7M -0.12% | 49.8M -0.26% | 49.9M -0.74% | |
Diluted Weighted Average Shares | 48.7M -2.72% | 50.1M -0.20% | 50.2M +0.58% | 49.9M -1.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 63.9M -34.75% | 97.9M +110.64% | 46.5M -20.55% | 58.5M +115.15% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 63.9M -34.75% | 97.9M +110.64% | 46.5M -20.55% | 58.5M +115.15% | |
Total Current Assets | 431.5M -3.76% | 448.3M +19.54% | 375.0M -4.26% | 391.7M +33.58% | |
Accumulated Depreciation | 88.9M +9.40% | 81.2M +12.27% | 72.4M +8.01% | 67.0M +10.34% | |
Property and Plant and Equipment and Net | 121.7M +63.24% | 74.5M -2.56% | 76.5M +8.66% | 70.4M -1.25% | |
Total Long-Term Assets | 10.9M +232.11% | 3.3M -42.83% | 5.7M +90.52% | 3.0M -8.19% | |
Total Assets | 3.5B +2.71% | 3.4B +2.53% | 3.3B -1.05% | 3.4B -8.63% | |
Income Taxes Payable | 447.4M +6.63% | 419.6M +3.96% | 403.6M +6.09% | 380.4M -14.49% | |
Total Short-Term Debt | 185.9M +12.18% | 165.7M -3.10% | 171.0M N/A | N/A N/A | |
Total Current Liabilities | 120.9M +13.41% | 106.6M -8.91% | 117.0M -27.17% | 160.7M +12.06% | |
Total Long-Term Debt | 994.0M +0.16% | 992.4M -11.85% | 1.1B -16.35% | 1.3B -8.86% | |
Total Long-Term Liabilities | 5.6M +3.51% | 5.4M -41.31% | 9.2M +12.49% | 8.2M +9.10% | |
Total Liabilities | 1.6B +2.52% | 1.6B -5.77% | 1.7B -12.76% | 1.9B -8.91% | |
Retained Earnings | 1.7B +12.23% | 1.6B +16.00% | 1.3B +18.50% | 1.1B -6.78% | |
Total Stockholders Equity | 1.9B +2.87% | 1.8B +10.86% | 1.7B +14.37% | 1.4B -8.27% | |
Total Shares Outstanding | 56.2M +0.36% | 56.0M +0.92% | 55.5M +1.17% | 54.9M +0.78% | |
Cash Flow | |||||
Cash from Operating Activities | 257.6M +2.43% | 251.5M +1.04% | 248.9M +8.36% | 229.7M -11.62% | |
Capital Expenditures | 11.2M +35.92% | 8.2M -13.88% | 9.6M +22.69% | 7.8M -19.27% | |
Cash from Investing Activities | -136.8M +684.10% | -17.5M -13.22% | -20.1M +73.61% | -11.6M -95.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -156.1M -14.29% | -182.1M -24.45% | -241.0M +29.69% | -185.8M +2,355.36% | |
Financials Ratio | |||||
Gross Margin | 54.54% -2.11% | 55.72% +0.41% | 55.49% +0.07% | 55.45% -2.91% | |
Operating Margin | 28.52% -3.74% | 29.63% -2.62% | 30.43% +1,630.92% | -1.99% -106.55% | |
Return on Assets | 5.52% -13.59% | 6.39% +1.78% | 6.28% +367.77% | -2.34% -140.51% | |
Return on Equity | 10.22% -16.86% | 12.30% -8.88% | 13.50% +347.99% | -5.44% -138.90% | |
Revenue Growth | -4.56% -557.27% | 1.00% +574.95% | -0.21% -105.58% | 3.76% -75.24% | |
Current Ratio | 3.57 -15.14% | 4.20 +31.23% | 3.20 +31.45% | 2.44 +19.20% | |
Cash Ratio | 0.53 -42.46% | 0.92 +131.23% | 0.40 +9.10% | 0.36 +92.03% | |
Debt-to-Equity Ratio | 0.63 -0.95% | 0.63 -19.45% | 0.78 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.34 -0.82% | 0.34 -12.90% | 0.39 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow